top of page

The Co-Founder of AI Proteins explains the benefits of designing de novo miniproteins as therapeutics

Chris Bahl walks through the attributes of miniproteins, something he is credited for pioneering, and describes potential uses and pipeline programs.





Comments


Join the BiotechTV mailing list

Thanks for subscribing!

bottom of page